Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan in compensated CHF and renal dysfunction
NCT01678794Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2012
- Primary completion
- Jun 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan in cardiorenal syndrome (CRS), sponsored by Mayo Clinic. Started Feb 2012; status: completed.
02
Drugs
candesartan
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT01678794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678794.